Stay updated on Safety of RGX-314 Gene Therapy in Neovascular AMD Clinical Trial

Sign up to get notified when there's something new on the Safety of RGX-314 Gene Therapy in Neovascular AMD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of RGX-314 Gene Therapy in Neovascular AMD Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer now shows site revision v3.7.1 instead of v3.7.0.
    Difference
    0.3%
    Check dated 2026-10-10T14:57:02.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The page continues to display a 403 Forbidden error in place of the clinical study record.
    Difference
    0.2%
    Check dated 2026-10-03T14:50:09.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The study page now presents a 403 Forbidden error instead of the study record, indicating restricted access to the page. The visible content shows a 403 message and site footer, signaling an access issue rather than updated study information.
    Difference
    18%
    Check dated 2026-09-19T18:54:35.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.5 to v3.6.6, indicating a backend/template update. This change does not modify the study content or the information presented on the page.
    Difference
    0.1%
    Check dated 2026-08-29T20:14:29.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    A site version tag was updated from v3.6.4 to v3.6.5, reflecting a routine platform version update.
    Difference
    0.1%
    Check dated 2026-08-08T15:18:40.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    The page received a deployment update to revision v3.6.4, replacing the prior v3.6.3. This likely includes minor fixes or refinements to the site’s behavior or layout without altering study content.
    Difference
    0.1%
    Check dated 2026-07-25T08:20:28.000Z thumbnail image

Stay in the know with updates to Safety of RGX-314 Gene Therapy in Neovascular AMD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of RGX-314 Gene Therapy in Neovascular AMD Clinical Trial page.